Literature DB >> 22842726

microrna expression signature of gastric cancer cells relative to normal gastric mucosa.

Bei-Qin Yu1, Li-Ping Su, Jian-Fang Li, Qu Cai, Min Yan, Xue-Hua Chen, Ying-Yan Yu, Qin-Long Gu, Zheng-Gang Zhu, Bing-Ya Liu.   

Abstract

micrornas (miRNAs) play an important role in a wide range of physiological and developmental processes by negatively regulating the expression of target genes at the post-transcriptional level. In this study, we investigated the differential miRNA expression signature between gastric cancer cells and normal gastric mucosa to determine changes in miRNA expression during gastric cancer development. We analyzed the global miRNA expression profiles of 9 gastric cancer cell lines and 6 normal gastric mucosa lines using miRNA microarrays. In addition, we performed quantitative real-time PCR (Q-PCR) to validate the results. Correlations between the miRNA expression profile and tumor clinicopathological parameters were analyzed. We found that 17 miRNAs were upregulated in gastric cancer cell lines and 146 miRNAs were downregulated compared to normal gastric mucosa. Using microarray data and Q-PCR validation, 15 miRNAs were finally selected. These candidate miRNAs were associated with gastric cancer clinicopathology to various degrees. High expression levels of hsa-miR-93 were found to predict poor survival (median, 16 vs. 40 months; log-rank test p<0.05). These findings suggest that miRNAs play vital roles in human gastric cancer. The findings may also provide clues toward understanding the molecular functions of miRNAs in various biological processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842726     DOI: 10.3892/mmr.2012.1006

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

1.  Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.

Authors:  Amanda L Treece; Daniel L Duncan; Weihua Tang; Sandra Elmore; Douglas R Morgan; Ricardo L Dominguez; Olga Speck; Michael O Meyers; Margaret L Gulley
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

Review 2.  Role of microRNAs in gastric cancer.

Authors:  Hideyuki Ishiguro; Masahiro Kimura; Hiromitsu Takeyama
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

3.  LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12.

Authors:  Jun Zhang; Hai-Yan Piao; Shuai Guo; Yue Wang; Tao Zhang; Zhi-Chao Zheng; Yan Zhao
Journal:  Int J Clin Oncol       Date:  2020-01-01       Impact factor: 3.402

4.  Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.

Authors:  Xin Zhang; Junling Liu; Dan Zang; Shu Wu; Aibin Liu; Jinrong Zhu; Geyan Wu; Jun Li; Lili Jiang
Journal:  Oncotarget       Date:  2015-06-20

5.  MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.

Authors:  Yu Zhao; Jie Huang; Li Zhang; Ying Qu; Jianfang Li; Beiqin Yu; Min Yan; Yingyan Yu; Bingya Liu; Zhenggang Zhu
Journal:  BMC Cancer       Date:  2014-01-21       Impact factor: 4.430

6.  Identification of Aberrantly Expressed miRNAs in Gastric Cancer.

Authors:  Dan Liu; Xiaowei Hu; Hongfeng Zhou; Guangyue Shi; Jin Wu
Journal:  Gastroenterol Res Pract       Date:  2014-06-01       Impact factor: 2.260

7.  miRNA: The nemesis of gastric cancer (Review).

Authors:  Xiaohui Xu; Xiaodong Yang; Chungen Xing; Shuyu Zhang; Jianping Cao
Journal:  Oncol Lett       Date:  2013-06-26       Impact factor: 2.967

Review 8.  MicroRNAs as diagnostic biomarkers in gastric cancer.

Authors:  Ying Yin; Jun Li; Shujie Chen; Tianhua Zhou; Jianmin Si
Journal:  Int J Mol Sci       Date:  2012-10-01       Impact factor: 5.923

9.  Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer.

Authors:  Yu Zhao; Chenglong Li; Ming Wang; Liping Su; Ying Qu; Jianfang Li; Beiqin Yu; Min Yan; Yingyan Yu; Bingya Liu; Zhenggang Zhu
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

10.  MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.

Authors:  Beiqin Yu; Xin Lv; Liping Su; Jianfang Li; Yingyan Yu; Qinlong Gu; Min Yan; Zhenggang Zhu; Bingya Liu
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.